Program GoalsClick here to register for this event
The purpose of this activity is to educate participants on the use of integrase inhibitors in clinical practice, and the differential risk associated with the patterns of integrase resistance observed. Integrase inhibitor(s) cross-resistance and available testing options for both genotypic and phenotypic drug susceptibility will be discussed.
Infectious Disease physicians, virologists, HIV specialists, clinical laboratory and other healthcare professionals interested in the management of HIV patients.
Upon completion of this activity, participants should be able to:
Joseph J. Eron, Jr., MD
- 05 minutes: Welcome & Introduction
Disclosure of Conflicts of Interests
Dane Garvin Ltd. (DGL) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted for fair balance, scientifice objectivity, and appropriateness of content.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this P.A.C.E.® accredited activity:
Planners and Managers
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this P.A.C.E.® accredited activity:
Credit Designation - Lab Professional, P.A.C.E.®
The American Society for Clinical Laboratory Science's Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program will provide 1.0 contact hour of credit.
How to Obtain P.A.C.E.® Credit
ACCREDITATION FOR THIS ACTIVITY HAS EXPIRED
Viewers are expected to complete the presentation before attempting to submit contact information and the session evaluation. Successful completion will lead to the issuance of a certificate for 1.0 contact hour of P.A.C.E.® approved continuing education. To receive credit, the course must be completed by October 1, 2012.
Participation in this activity should be completed in approximately 1 hours. Please follow these steps in order to receive P.A.C.E.® credit for viewing the webcast:
Should you have any P.A.C.E.® questions regarding this activity, please contact:
For technical difficulties, please consult our Technical Instructions.
Release and Expiration
Enduring Archive Release date: October 1, 2011
Enduring Archive Expiration date: October 1, 2012
There is no fee for this educational activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The American Society for Clinical Laboratory Science (ASCLS) and Dane Garvin Ltd. (DGL) do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Policy on Privacy and Confidentiality
Dane Garvin Ltd. (DGL) protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. DGL and our educational joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
Dane Garvin Ltd. and the American Society for Clinical Laboratory Science maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
The opinions expressed in this educational activity are those of the faculty and do not reflect the views of Dane Garvin Ltd. and/or the American Society for Clinical Laboratory Science. This educational activity may discuss off-label and/or investigational uses and dosages for therapeutic products/procedures that have not been approved by the United States Food and Drug Administration (FDA). Dane Garvin Ltd. and the American Society for Clinical Laboratory Science do not recommend the use of any product/procedure outside of the labeled indications. A qualified health care professional should be consulted before using any therapeutic product/procedure discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity. Please refer to the official prescribing information for each product/procedures for approved indication, contraindications, and warnings.
This program has been made available online.
"Integrase Inhibitor Drug Resistance in Clinical Practice"
This activity is co-sponsored by the Association for Molecular Pathology.
Commercial Support Statement
This activity supported by an educational grant from Abbott Molecular.
Copyright © October 1, 2011 - October 1, 2012. Dane Garvin, Ltd. All Rights Reserved. Permission for accreditation is granted to the American Society for Clinical Laboratory Science.